Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to Supply InterGenetics $7.5M of Reagents for Breast-Cancer Test

NEW YORK, June 30 (GenomeWeb News) - Tm Bioscience has signed a five-year, $7.5 million agreement to supply InterGenetics with custom Tag-It reagents for its OncoVue breast cancer-risk test, the companies said today.


"With a potential market of over 30 million tests, growing at 2 million tests per year in the US alone, we needed to select a production technology which was scalable for very high throughput," Craig Shimasaki, president and CEO of Oklahoma City, Okla.-based InterGenetics, said in the statement. "Our OncoVue breast cancer risk test was actually designed and developed using the Tag-It universal array platform."


Tm said it plans to begin supplying products to InterGenetics in the second half of 2005. As InterGenetics completes clinical validation of additional genetic markers for ovarian and other cancers, "we anticipate expanding our agreement to include these new cancer risk assessment products," Greg Hines, president and CEO of Tm Bioscience, said in the statement.


The American Cancer Society estimates approximately 211,000 women in the United Stateswill be diagnosed with invasive breast cancer this year, the statement added. Screening by mammography is recommended annually for women over 40 with an estimated 30 million mammograms performed each year on women between the ages of 40 and 64.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.